The increased expression observed for the CCNA1 gene in the PTC group compared to the group of normal and benign samples, and its reduced expression in the FTC group when compared to the PTC samples, in both the PCR Array and RT-qPCR analyses, suggests this gene as a potential diagnostic marker in PTC. This evidence concerns the gene CCNA1 and thyroid cancer, nonmedullary, 2.